Atlas Trials

Lung Cancer Non-small Cell Stage IV

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lung Cancer Non-small Cell Stage IV

RecordFirmDate
Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer (NCT05127382)Hellenic Cooperative Oncology Group2020-02-01
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC (NCT03769103)British Columbia Cancer Agency2019-03-19
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients (NCT04184921)Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2019-01-01
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer (NCT03866980)Akeso2018-11-27
Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform (NCT03692442)Guangzhou Institute of Respiratory Disease2018-05-01
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy (NCT02129699)ETOP IBCSG Partners Foundation2015-01-06

Track Lung Cancer Non-small Cell Stage IV automatically

Every clearance here is in the API, with alerts when new ones post.